The U.S. Food and Drug Administration (FDA) has granted orphan drug status to Gesynta Pharma’s GS-248, its oral therapy…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
High levels of a form of the CD146 protein, normally found on endothelial cells — those that line blood vessel…
People with systemic sclerosis (SSc) vaccinated for COVID-19 fare well, with no serious adverse events and a low rate of reported…
Poor oxygenation in skeletal muscles — those used in voluntary movements — contributes to impaired exercise capacity in people with…
Chemomab Therapeutics is teaming up with the University of Leeds to investigate the role of the protein CCL24 in…
Having pulmonary hypertension shortens survival in people with scleroderma, also called systemic sclerosis (SSc), according to a Brazilian…
The fecal microbiome — the community of microbes present in stools — of scleroderma patients is more diverse than that…
Sexual dysfunction is common among both men and women with scleroderma (SSc), a review study says. According to the…
An international survey found that the ability to use one’s hands, physical symptoms, and the chance to prevent more severe…
Ahead of this year’s Rare Disease Week on Capitol Hill, held virtually July 14–22, the EveryLife Foundation will…